Texas Instruments: Paying 36x trough earnings for a cyclical recovery that's already half-priced

Stevie AI on Texas Instruments Incorporated (TXN-USA | texasinstrum)

10/26/2026

Summary

Texas Instruments designs and manufactures analog and embedded processing semiconductors sold into industrial, automotive, data-center, personal electronics, and communications end markets, operating owned 300mm fabs predominantly in the US. The structural insight is that TI's FY2025 numbers represent a trough from which industrial and data-center demand is now recovering, but the stock at $285.63 already capitalizes several years of that recovery, leaving limited room for multiple expansion even as earnings grow meaningfully. The key question for investors is not whether TI's earnings power improves — it clearly does — but whether the embedded cyclical recovery assumptions justify a price that implies roughly 50x trailing FY2025 EPS of $5.45 and still nearly 37x FY2026 consensus-aligned EPS of $5.76. Recent financials show the trough-to-recovery dynamic directly: FY2024 revenue of $15.6B and net income of $4.8B (EPS $5.20) gave way to FY2025 revenue of $17.7B and net income of $5.0B (EPS $5.45) — a reasonable 13% revenue increase but a far more modest 5% net income increase, reflecting margin pressure from elevated depreciation tied to capacity investment and a less favorable mix. Free cash flow generation remains solid but capital intensive, with capex guided to the high end of $2-3B in 2026 and rising through 2029, funded by operating cash flow plus incremental debt that pushes net debt from an implied base toward $15.7B by FY2029. Our price targets are built off the EPS path of $5.76 (FY2026) to $7.85 (FY2029), applying a 24x forward P/E — a premium analog-semiconductor multiple reflecting TI's structural margin durability and capital-return discipline, but below the stock's current implied multiple, reflecting our view that the market has already priced in the fall-through framework working as management describes. This yields price targets of roughly $138 in FY2026 rising to $188 by FY2029 — materially below the current $285.63 price, implying the stock trades well ahead of what we believe is a fair multiple on a normalized, through-cycle earnings basis, hence our HOLD rating despite genuine improvement in the underlying business.

Thesis

1. **Durable Competitive Position in Analog/Embedded, But Not Infinite Pricing Power**: TI's owned 300mm fab footprint, concentrated in the US, gives it a structural cost advantage over fabless peers reliant on foundry capacity, and its breadth of tens of thousands of analog and embedded parts creates switching costs for industrial and automotive customers who design TI parts into decade-long platforms. This is a real and durable advantage, scored appropriately high on strategic sustainability in our framework. However, this advantage is about defending share and margin in a mature, contested market — not about expanding total addressable market or pricing power beyond what cyclical semiconductor demand allows, which caps the multiple investors should reasonably pay versus high-growth semiconductor peers. 2. **Margin Expansion Is Real but Already the Base Case Embedded in Consensus**: Management's 75-85% incremental fall-through framework is credible given TI's largely fixed-cost manufacturing base, and Embedded Processing margin expansion of roughly 10 points YoY recently supports the idea that operating leverage is working. Net income growing from $5.0B in FY2025 to $6.8B in FY2029 on revenue growth from $17.7B to $23.4B (a 32% revenue increase driving a 36% net income increase) is consistent with this framework playing out as described. But this is precisely the scenario the current share price already assumes; the market is not underestimating margin recovery, it may be over-extrapolating its durability. 3. **Capital Allocation Discipline Supports the Floor, Not the Upside**: With $18.79B of remaining buyback authorization and a stated objective of growing free cash flow per share, TI will continue returning capital aggressively, providing some technical support to the stock and dampening downside volatility. FCF grows from $5.0B (FY2026) to $6.5B (FY2029), a healthy trajectory. However, capex of $2.9-3.5B annually plus rising net debt (from $13.1B to $15.7B over the forecast horizon) means buybacks are increasingly debt-funded rather than purely FCF-funded, which is a lower-quality form of capital return that should not command a premium multiple. 4. **Mispricing Is Asymmetric to the Downside**: At $285.63, the stock implies a forward P/E near 37x on FY2026 EPS of $5.76 and still roughly 26x on FY2029 EPS of $7.85 — multiples typically reserved for secular growth semiconductor names with 20%+ revenue CAGRs, not a company growing revenue at a 9% FY2026 rate off a cyclical trough with mid-single-digit growth decelerating thereafter. The market appears to be pricing a

Risks

,

📈 Price Targets